An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
StatPearls [Internet].
Treasure Island (FL): StatPearls Publishing; 2025 Jan-.
Top results in this bookTable of Contents
Database of Abstracts of Reviews of Effects (DARE): Quality-assessed Reviews [Internet].
York (UK): Centre for Reviews and Dissemination (UK); 1995-.
GeneReviews® [Internet].
Adam MP, Bick S, Mirzaa GM, et al., editors.
Seattle (WA): University of Washington, Seattle; 1993-2026.
Parkinson’s disease in adults: diagnosis and management.
London: National Institute for Health and Care Excellence (NICE); 2017 Jul. (NICE Guideline, No. 71.)
Specialist rehabilitation for people with Parkinson’s disease in the community: a randomised controlled trial.
Gage H, Grainger L, Ting S, et al.
Southampton (UK): NIHR Journals Library; 2014 Dec. (Health Services and Delivery Research, No. 2.51.)
Dementia: Assessment, management and support for people living with dementia and their carers.
London: National Institute for Health and Care Excellence (NICE); 2018 Jun. (NICE Guideline, No. 97.)
Rotigotine (Neupro) (Transdermal Patch) [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2016 Nov.
Preventing and Treating Dementia: Research Priorities to Accelerate Progress.
National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Behavioral and Social Sciences and Education; Board on Health Sciences Policy; Board on Behavioral, Cognitive, and Sensory Sciences; Committee on Research Priorities for Preventing and Treating Alzheimer’s Disease and Related Dementias; Yost OC, Downey A, Powell T, editors.
Washington (DC): National Academies Press (US); 2025 Mar 24.
Parkinson’s Disease: Pathogenesis and Clinical Aspects [Internet].
Stoker TB, Greenland JC, editors.
Brisbane (AU): Codon Publications; 2018 Dec 21.
Improving the diagnosis and management of Lewy body dementia: the DIAMOND-Lewy research programme including pilot cluster RCT.
O’Brien JT, Taylor JP, Thomas A, et al.
Southampton (UK): NIHR Journals Library; 2021 Jul. (Programme Grants for Applied Research, No. 9.7.)
Where are We? Continuous Dopaminergic Stimulation for Parkinson's Disease [Internet].
Odin P, Chaudhuri KR, Aquilonious SM, et al., editors.
Berkshire (UK): Empowering Strategic Performance Ltd; 2023 Jan 1.
Clinical effectiveness and cost-effectiveness of physiotherapy and occupational therapy versus no therapy in mild to moderate Parkinson’s disease: a large pragmatic randomised controlled trial (PD REHAB).
Clarke CE, Patel S, Ives N, et al.; on behalf of the PD REHAB Collaborative Group.
Southampton (UK): NIHR Journals Library; 2016 Aug. (Health Technology Assessment, No. 20.63.)
LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet].
Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012-.
Machine Learning for Brain Disorders [Internet].
Colliot O, editor.
New York, NY: Humana; 2023.
Foslevodopa-Foscarbidopa (Vyalev): CADTH Reimbursement Review: Therapeutic area: Parkinson disease [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2023 Sep.
Basic Neurochemistry: Molecular, Cellular and Medical Aspects. 6th edition.
Siegel GJ, Agranoff BW, Albers RW, et al., editors.
Philadelphia: Lippincott-Raven; 1999.
Diagnosis and Treatment of Clinical Alzheimer’s-Type Dementia: A Systematic Review [Internet].
Fink HA, Hemmy LS, Linskens EJ, et al.
Rockville (MD): Agency for Healthcare Research and Quality (US); 2020 Apr. (Comparative Effectiveness Review, No. 223.)
Clinical Review Report: Levodopa/Carbidopa (Duodopa): (Abbvie Corporation): Indication: For the treatment of patients with advanced levodopa-responsive Parkinson’s disease who do not have satisfactory control of severe, debilitating motor fluctuations and hyper-/dyskinesia despite optimized treatment with available combinations of Parkinson’s medicinal products, and, for whom the benefits of this treatment may outweigh the risks associated with the insertion and long-term use of the percutaneous endoscopic gastrostomy-jejunostomy (PEG-J) tube required for administration [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2018 Sep.
NTP Research Report on the Scoping Review of Paraquat Dichloride Exposure and Parkinson’s Disease: Research Report 16 [Internet].
Boyd WA, Blain RB, Skuce CR, et al.
Research Triangle Park (NC): National Toxicology Program; 2020 Sep.
Madame Curie Bioscience Database [Internet].
Austin (TX): Landes Bioscience; 2000-2013.
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on